⚠ Official Notice: www.ijisrt.com is the official website of the International Journal of Innovative Science and Research Technology (IJISRT) Journal for research paper submission and publication. Please beware of fake or duplicate websites using the IJISRT name.



The Oncology Landscape: Molecular Pathophysiology, Diagnostics and Emerging Therapeutics


Authors : Md Afaque Ali; Rajeev Ranjan Kumar

Volume/Issue : Volume 11 - 2026, Issue 10 - October

Google Scholar : https://tinyurl.com/wsr3v2vm

DOI : https://doi.org/10.38124/ijisrt/26Oct240

Semantic Scholar

ResearchGate

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Cancer is a very complicated complex and diverse disease that affects millions around the world; it remains one of the leading causes of global toll even though there have been tremendous advancements in cancer research and development. The purpose of this paper is to provide a current overview of what we know about cancer and how it develops. We will discuss the etiology (cause), diagnosis and treatment methods for many common types of cancer including Breast, Gastric, Pancreatic, Oral, Prostate, Gallbladder, Colorectal, Thyroid and Ovarian Cancers. The progression of cancer is primarily due to a combination of genetic mutation(s), epigenetic changes, chronic inflammation and disrupted cell-to-cell adhesion. Of all these factors, inflammation is a significant contributor to both the development and spread of cancer and thus positions immunotherapy as a novel, state-of-the-art approach to treating cancer. In addition to traditional approaches to treating cancer (e.g., Surgery, Chemotherapy, Radiation Therapy), clinicians now have access to a variety of cutting-edge approaches such as Immunotherapy and Gene Therapy.

Keywords : Cancer, Breast Cancer, Radiation Therapy, Epigenetic Therapy, Nanotechnology.

References :

  1. Hausman DM. What Is Cancer? PerspectBiol Med. 2019;62(4):778-784. https://doi.org/10.1353/pbm.2019.0046 PMid:31761807
  2. Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807-821.https://doi.org/10.1038/s41423-020-0488-6 PMid:32612154 PMCid:PMC7395159
  3. Imran A, Qamar HY, Ali Q, Naeem H, Riaz M, Amin S, Kanwal N, Ali F, Sabar MF, Nasir IA. Role of Molecular Biology in Cancer Treatment: A Review Article. Iran J Public Health. 2017;46(11):1475-1485.
  4. Upadhyay A. Cancer: An unknown territory; rethinking before going ahead. Genes Dis. 2020;8(5):655-661.https://doi.org/10.1016/j.gendis.2020.09.002 PMid:34291136 PMCid:PMC8278524
  5. Piña-Sánchez P, Chávez-González A, Ruiz-Tachiquín M, Vadillo E, Monroy-García A, Montesinos JJ, Grajales R, Gutiérrez de la Barrera M, Mayani H. Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective. Cancer Control. 2021;28:10732748211038735. https://doi.org/10.1177/10732748211038735 PMid:34565215 PMCid:PMC8481752
  6. Paleari L. Personalized Assessment for Cancer Prevention, Detection, and Treatment. Int J Mol Sci. 2024;25(15):8140. https://doi.org/10.3390/ijms25158140 PMid:39125710 PMCid:PMC11311957
  7. Okamoto A, Watanabe T, Kamata K, Minaga K, Kudo M. Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis. Intern Med. 2019;58(11):1533-1539. https://doi.org/10.2169/internalmedicine.2210-18 PMid:30713326 PMCid:PMC6599917
  8. Dzobo K, Senthebane DA, Ganz C, Thomford NE, Wonkam A, Dandara C. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review. Cells. 2020;9(8):1896. https://doi.org/10.3390/cells9081896 PMid:32823711 PMCid:PMC7464860
  9. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16-27. https://doi.org/10.1158/1055-9965.EPI-15-0578 PMid:26667886
  10. Obeagu EI, Obeagu GU. Breast cancer: A review of risk factors and diagnosis. Medicine (Baltimore). 2024;103(3):e36905. https://doi.org/10.1097/MD.0000000000036905 PMid:38241592 PMCid:PMC10798762
  11. Bates JP, Derakhshandeh R, Jones L, Webb TJ. Mechanisms of immune evasion in breast cancer. BMC Cancer. 2018;18(1):556. https://doi.org/10.1186/s12885-018-4441-3 PMid:29751789 PMCid:PMC5948714
  12. Seeneevassen L, Bessède E, Mégraud F, Lehours P, Dubus P, Varon C. Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies. Int J Mol Sci. 2021;22(7):3418. https://doi.org/10.3390/ijms22073418 PMid:33810350 PMCid:PMC8037554
  13. Mamun TI, Younus S, Rahman MH. Gastric cancer-Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treat Res Commun. 2024;41:100845. https://doi.org/10.1016/j.ctarc.2024.100845 PMid:39357127
  14. Lv L, Liang X, Wu D, Wang F, Zhang Y, Cang H, Deng X, Li M. Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer. J Cancer. 2021;12(8):2385-2394. https://doi.org/10.7150/jca.51433 PMid:33758614 PMCid:PMC7974896
  15. Lilly AC, Astsaturov I, Golemis EA. Intrapancreatic fat, pancreatitis, and pancreatic cancer. Cell Mol Life Sci. 2023;80(8):206. https://doi.org/10.1007/s00018-023-04855-z PMid:37452870 PMCid:PMC10349727
  16. Mak AL, Wassenaar N, van Dijk AM, Troelstra M, Houttu V, van Son K, Driessen S, Zwirs D, van den Berg-Faay S, Shumbayawonda E, Runge J, Doukas M, Verheij J, Beuers U, Nieuwdorp M, Cahen DL, Nederveen A, Gurney-Champion O, Holleboom A. Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease. JHEP Rep. 2024;6(3):100998. https://doi.org/10.1016/j.jhepr.2023.100998 PMid:38379586 PMCid:PMC10877191
  17. Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev GastroenterolHepatol. 2021;18(7):493-502. https://doi.org/10.1038/s41575-021-00457-x PMid:34002083 PMCid:PMC9265847
  18. Khayatan D, Hussain A, Tebyaniyan H. Exploring animal models in oral cancer research and clinical intervention: A critical review. Vet Med Sci. 2023;9(4):1833-1847.https://doi.org/10.1002/vms3.1161 PMid:37196179 PMCid:PMC10357283
  19. Inchingolo F, Santacroce L, Ballini A, Topi S, Dipalma G, Haxhirexha K, Bottalico L, Charitos IA. Oral Cancer: A Historical Review. Int J Environ Res Public Health. 2020 May 2;17(9):3168. https://doi.org/10.3390/ijerph17093168 PMid:32370133 PMCid:PMC7246763
  20. Warnakulasuriya S, Kerr AR. Oral Cancer Screening: Past, Present, and Future. J Dent Res. 2021;100(12):1313-1320. https://doi.org/10.1177/00220345211014795 PMid:34036828 PMCid:PMC8529297
  21. Yuwanati M, Gondivkar S, Sarode SC, Gadbail A, Desai A, Mhaske S, Pathak SK, N Khatib M. Oral health-related quality of life in oral cancer patients: systematic review and meta-analysis. Future Oncol. 2021;17(8):979-990. https://doi.org/10.2217/fon-2020-0881 PMid:33541115
  22. Szewczyk M, Pazdrowski J, Golusiński P, Więckowska B, Golusiński W. Oral cancer in young adults: should we approach these patients differently? Front Oncol. 2024;14:1297752. https://doi.org/10.3389/fonc.2024.1297752 PMid:38646430 PMCid:PMC11026602
  23. Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van derKwast T, Bristow RG. Prostate cancer. Nat Rev Dis Primers. 2021;7(1):9. https://doi.org/10.1038/s41572-020-00243-0 PMid:33542230
  24. Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. 2022 Sep 5;27(17):5730. https://doi.org/10.3390/molecules27175730 PMid:36080493 PMCid:PMC9457814
  25. Costello AJ. Considering the role of radical prostatectomy in 21st century prostate cancer care. Nat Rev Urol. 2020;17(3):177-188. https://doi.org/10.1038/s41585-020-0287-y PMid:32086498
  26. Williams IS, McVey A, Perera S, O'Brien JS, Kostos L, Chen K, Siva S, Azad AA, Murphy DG, Kasivisvanathan V, Lawrentschuk N, Frydenberg M. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022;217(8):424-433. https://doi.org/10.5694/mja2.51722 PMid:36183329 PMCid:PMC9828197
  27. Chaturvedi A, Kumar V, Gupta S. Molecular Oncology of Gall Bladder Cancer. Indian J SurgOncol. 2021 Apr;12(Suppl 1):57-64. https://doi.org/10.1007/s13193-019-01008-2 PMid:33994729 PMCid:PMC8119519
  28. Sturm N, Schuhbaur JS, Hüttner F, Perkhofer L, Ettrich TJ. Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions. Cancers (Basel). 2022;14(22):5580. https://doi.org/10.3390/cancers14225580 PMid:36428670 PMCid:PMC9688543
  29. Lam R, Zakko A, Petrov JC, Kumar P, Duffy AJ, Muniraj T. Gallbladder Disorders: A Comprehensive Review. Dis Mon. 2021;67(7):101130.https://doi.org/10.1016/j.disamonth.2021.101130 PMid:33478678
  30. Deqing LC, Zhang JW, Yang J. Endoscopic diagnosis and management of gallbladder carcinoma in minimally invasive era: New needs, new models. World J GastrointestOncol. 2024;16(11):4333-4337. https://doi.org/10.4251/wjgo.v16.i11.4333 PMid:39554749 PMCid:PMC11551627
  31. Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, Lim YC, Kibria KMK, Mohiuddin AKM, Ming LC, Goh KW, Hadi MA. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers (Basel). 2022;14(7):1732. https://doi.org/10.3390/cancers14071732 PMid:35406504 PMCid:PMC8996939
  32. Islam MR, Akash S, Rahman MM, Nowrin FT, Akter T, Shohag S, Rauf A, Aljohani ASM, Simal-Gandara J. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. ChemBiol Interact. 2022;368:110170. https://doi.org/10.1016/j.cbi.2022.110170 PMid:36202214
  33. Wilkinson N. Management of Rectal Cancer. SurgClin North Am. 2020;100(3):615-628. https://doi.org/10.1016/j.suc.2020.02.014 PMid:32402304
  34. Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021;35(11-12):787-820. https://doi.org/10.1101/gad.348226.120 PMid:34074695 PMCid:PMC8168558
  35. Marcellinaro R, Spoletini D, Grieco M, Avella P, Cappuccio M, Troiano R, Lisi G, Garbarino GM, Carlini M. Colorectal Cancer: Current Updates and Future Perspectives. J Clin Med. 2023;13(1):40. https://doi.org/10.3390/jcm13010040 PMid:38202047 PMCid:PMC10780254
  36. Laha D, Nilubol N, Boufraqech M. New Therapies for Advanced Thyroid Cancer. Front Endocrinol (Lausanne). 2020;11:82. https://doi.org/10.3389/fendo.2020.00082 PMid:32528402 PMCid:PMC7257776
  37. Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer. 2021;149(5):984-992. https://doi.org/10.1002/ijc.33690 PMid:34013533
  38. Qu H, He C, Xu H, Ren X, Sun X, Xu Y. Occupational radiation exposure and risk of thyroid cancer: A meta analysis of cohort studies. OncolLett. 2024;28(3):437. https://doi.org/10.3892/ol.2024.14570 PMid:39081964 PMCid:PMC11287109
  39. Lynam S, Lugade AA, Odunsi K. Immunotherapy for Gynecologic Cancer: Current Applications and Future Directions. ClinObstet Gynecol. 2020;63(1):48-63.https://doi.org/10.1097/GRF.0000000000000513 PMid:31833846 PMCid:PMC7298668
  40. Maiorino L, Daßler-Plenker J, Sun L, Egeblad M. Innate Immunity and Cancer Pathophysiology. Annu Rev Pathol. 2022;17:425-457. https://doi.org/10.1146/annurev-pathmechdis-032221-115501 PMid:34788549 PMCid:PMC9012188
  41. Yayan J, Franke KJ, Berger M, Windisch W, Rasche K. Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review. Mol Biol Rep. 2024;51(1):165. https://doi.org/10.1007/s11033-023-08920-5 PMid:38252369 PMCid:PMC10803487
  42. Vaghari-Tabari M, Ferns GA, Qujeq D, Andevari AN, Sabahi Z, Moein S. Signaling, metabolism, and cancer: An important relationship for therapeutic intervention. J Cell Physiol. 2021;236(8):5512-5532. https://doi.org/10.1002/jcp.30276 PMid:33580511
  43. Smith RD, Mallath MK. History of the Growing Burden of Cancer in India: From Antiquity to the 21st Century. J Glob Oncol. 2019;5:1-15. https://doi.org/10.1200/JGO.19.00048 PMid:31373840 PMCid:PMC7010436
  44. Blackadar CB. Historical review of the causes of cancer. World J ClinOncol. 2016;7(1):54-86.https://doi.org/10.5306/wjco.v7.i1.54 PMid:26862491 PMCid:PMC4734938
  45. Hazafa A, Rehman KU, Jahan N, Jabeen Z. The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells. Nutr Cancer. 2020;72(3):386-397.https://doi.org/10.1080/01635581.2019.1637006 PMid:31287738
  46. Kaur R, Bhardwaj A, Gupta S. Cancer treatment therapies: traditional to modern approaches to combat cancers. Mol Biol Rep. 2023;50(11):9663-9
  47. Zafar A, Khan MJ, Abu J, Naeem A. Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy. Mol Biol Rep. 2024;51(1):219. https://doi.org/10.1007/s11033-023-09096-8 PMid:38281269 PMCid:PMC10822809
  48. Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, Sastry N, Hu B, Cheng SY. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10(19):8721-8743. https://doi.org/10.7150/thno.41648 PMid:32754274 PMCid:PMC7392012
  49. Mosleh-Shirazi S, Abbasi M, Moaddeli MR, Vaez A, Shafiee M, Kasaee SR, Amani AM, Hatam S. Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview. Nanotheranostics. 2022;6(4):400-423. https://doi.org/10.7150/ntno.74613 PMid:36051855 PMCid:PMC9428923
  50. Nasir A, Khan A, Li J, Naeem M, Khalil AAK, Khan K, Qasim M. Nanotechnology, A Tool for Diagnostics and Treatment of Cancer. Curr Top Med Chem. 2021;21(15):1360-1376.https://doi.org/10.2174/1568026621666210701144124 PMid:34218784
  51. Ghasemi S. Cancer's epigenetic drugs: where are they in the cancer medicines? Pharmacogenomics J. 2020;20(3):367-379. https://doi.org/10.1038/s41397-019-0138-5 PMid:31819161

Cancer is a very complicated complex and diverse disease that affects millions around the world; it remains one of the leading causes of global toll even though there have been tremendous advancements in cancer research and development. The purpose of this paper is to provide a current overview of what we know about cancer and how it develops. We will discuss the etiology (cause), diagnosis and treatment methods for many common types of cancer including Breast, Gastric, Pancreatic, Oral, Prostate, Gallbladder, Colorectal, Thyroid and Ovarian Cancers. The progression of cancer is primarily due to a combination of genetic mutation(s), epigenetic changes, chronic inflammation and disrupted cell-to-cell adhesion. Of all these factors, inflammation is a significant contributor to both the development and spread of cancer and thus positions immunotherapy as a novel, state-of-the-art approach to treating cancer. In addition to traditional approaches to treating cancer (e.g., Surgery, Chemotherapy, Radiation Therapy), clinicians now have access to a variety of cutting-edge approaches such as Immunotherapy and Gene Therapy.

Keywords : Cancer, Breast Cancer, Radiation Therapy, Epigenetic Therapy, Nanotechnology.

Paper Submission Last Date
31 - October - 2026

SUBMIT YOUR PAPER CALL FOR PAPERS
Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe